Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Savara Inc Director's Dealing 2010

May 27, 2010

32709_dirs_2010-05-27_9f286e22-bc9d-40fc-bcd3-4b22d9f8f718.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ADVENTRX PHARMACEUTICALS INC (ANX)
CIK: 0001160308
Period of Report: 2010-05-27

Reporting Person: Culley Brian M (Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-05-27 Common Stock P 5000 $1.89 Acquired 5000 Direct